However, in a recent study, researchers from Memorial Sloan Kettering Cancer Center reported a case of lung adenocarcinoma with EGFR L858R mutation, where MET gene exon 14 skipping mutation (c.2899G>A) occurred after resistance to erlotinib treatment. The gene discussed is MET; the disease is lung adenocarcinoma.